CONFALONIERI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 12.526
EU - Europa 11.086
AS - Asia 5.338
SA - Sud America 531
AF - Africa 97
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 13
Totale 29.664
Nazione #
US - Stati Uniti d'America 12.369
RU - Federazione Russa 3.437
IT - Italia 2.393
SG - Singapore 1.791
PL - Polonia 1.524
HK - Hong Kong 1.323
CN - Cina 1.134
SE - Svezia 803
DE - Germania 527
TR - Turchia 485
BR - Brasile 398
UA - Ucraina 358
BG - Bulgaria 336
IE - Irlanda 327
NL - Olanda 290
FR - Francia 208
GB - Regno Unito 208
FI - Finlandia 147
IN - India 110
AT - Austria 97
VN - Vietnam 93
CH - Svizzera 88
ES - Italia 86
CA - Canada 76
KR - Corea 74
BE - Belgio 66
MX - Messico 64
JP - Giappone 62
AU - Australia 61
IR - Iran 43
CO - Colombia 41
TW - Taiwan 39
SN - Senegal 30
AR - Argentina 29
GR - Grecia 26
CZ - Repubblica Ceca 24
PK - Pakistan 24
EG - Egitto 21
SI - Slovenia 21
CL - Cile 20
PT - Portogallo 20
TH - Thailandia 20
IL - Israele 18
NO - Norvegia 18
PE - Perù 16
RO - Romania 15
EC - Ecuador 14
BD - Bangladesh 13
EU - Europa 13
SA - Arabia Saudita 13
HR - Croazia 12
ID - Indonesia 12
NZ - Nuova Zelanda 12
ZA - Sudafrica 12
PH - Filippine 10
DK - Danimarca 9
MY - Malesia 9
RS - Serbia 9
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
IQ - Iraq 8
LT - Lituania 8
MA - Marocco 7
UZ - Uzbekistan 7
ET - Etiopia 6
JO - Giordania 6
TN - Tunisia 6
AZ - Azerbaigian 5
LA - Repubblica Popolare Democratica del Laos 5
PY - Paraguay 5
BO - Bolivia 4
KE - Kenya 4
LU - Lussemburgo 4
PA - Panama 4
CI - Costa d'Avorio 3
CM - Camerun 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
YE - Yemen 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
Totale 29.651
Città #
Moscow 3.206
Warsaw 1.515
Fairfield 1.433
Hong Kong 1.301
Chandler 1.005
Singapore 944
Woodbridge 882
Ashburn 852
Wilmington 795
Houston 695
Seattle 645
Trieste 589
Princeton 516
Cambridge 505
Ann Arbor 482
Boardman 452
Jacksonville 421
Izmir 392
Columbus 363
Sofia 333
Dublin 302
Wellsboro 275
Beijing 256
Santa Clara 203
Milan 145
San Diego 113
The Dalles 86
Redwood City 85
Rome 81
Redmond 78
Dong Ket 71
Helsinki 71
Los Angeles 69
Vienna 65
Dearborn 64
North Bergen 64
Nuremberg 60
Brussels 55
Seoul 55
Bern 51
Dongguan 49
Lappeenranta 49
Düsseldorf 48
Norwalk 47
Frankfurt am Main 41
Naples 41
Kocaeli 40
Guangzhou 38
Bremen 37
Phoenix 36
Venezia 35
Shanghai 33
São Paulo 33
Cividale del Friuli 32
Jinan 31
Udine 31
Dakar 30
Florence 29
London 27
Pune 27
Chicago 26
Dallas 26
Paris 26
Sydney 26
Boydton 25
Grafing 25
Turin 24
Washington 24
Buffalo 23
Hefei 23
Bari 22
Des Moines 22
Istanbul 22
Nanjing 22
Barcelona 21
Falls Church 21
Lauterbourg 21
Treviso 21
Bogotá 20
Fremont 20
Zhengzhou 20
Portsmouth 19
Toronto 19
Taipei 18
Tokyo 18
Bologna 17
Council Bluffs 17
New York 17
Arzene 16
Kranj 16
Palermo 16
Torre Del Greco 16
Tucson 16
Duino-Aurisina 15
Kunming 15
Munich 15
Padova 15
Athens 14
Madrid 14
Amsterdam 13
Totale 21.095
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.080
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 398
The Time to Offer Treatments for COVID-19 363
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 340
Acute respiratory distress syndrome 335
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 302
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 281
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 280
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 268
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 254
Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease 249
Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey 241
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease. 239
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 236
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 235
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 228
A retrospective study of endobronchial ultrasound transbronchial needle aspiration versus conventional transbronchial needle aspiration in diagnosis/staging of hilar/mediastinal lymph node in lung cancer: Which role in clinical practice? 227
Deep sedation versus minimal sedation during endobronchial ultrasound transbronchial needle aspiration 224
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 220
Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors 210
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 189
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 188
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 183
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 182
Alveolar Epithelial Type II Cells 177
High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection 176
Epidemiology of Tuberculosis and the Rise of XDR-TB 176
A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome 176
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 170
Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage 169
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 165
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 163
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 163
null 161
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. 160
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 155
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 155
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 152
Towards synchrotron phase-contrast lung imaging in patients - a proof-of-concept study on porcine lungs in a human-scale chest phantom. 152
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 150
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 150
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 149
Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation 145
Left ventricular thrombectomy in myocarditis: the epicardial scan & video-assisted transaortic approach 142
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 139
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 137
Sildenafil in pulmonary arterial hypertension. 135
Can rheology be useful in the cystic fibrosis frame 134
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 132
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 131
Burden of chronic obstructive pulmonary disease 130
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 128
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 128
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 126
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 125
The value and scope of subspecialty biomedical journals: Perspectives from either side of the Atlantic. 124
Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study 124
Increased number and expertise of Italian respiratory high-dependency care units: The second national survey 123
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 121
Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review 121
Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD: Are there new key cornerstones? 118
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 117
Monitoring sputum properties in cystic fibrosis patients by means of Low-Field NMR before after kaftrio treatment 116
Documento AIPO-SIMeR sulla Fibrosi Polmonare Idiopatica 116
Effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 115
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 115
Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis 114
Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit 113
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 112
Chronic Thromboembolic Pulmonary Hypertension: An Update 112
Approccio pragmatico alla diagnosi di polmonite da SARS-CoV-2 (COVID-19). Dalla fase epidemica alle fasi due e tre. 111
Noninvasive ventilation 109
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 109
The appropriate setting of noninvasive pressure support ventilation in stable COPD patients 108
The Treatment of Lung Involvement in Systemic Sclerosis 106
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 105
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 104
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 104
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 104
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 103
Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: An observational study 103
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 103
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 103
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: An open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days 102
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 101
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 100
Inspiratory muscle training for diaphragm dysfunction after cardiac surgery 100
Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement 99
The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 99
Glucocorticoid treatment in community-acquired pneumonia without severe sepsis: No evidence of efficacy 98
Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study 98
Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 98
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 97
Opening of a respiratory intermediate care unit in a general hospital: Impact on mortality and other outcomes 97
Bosentan for patients with chronic thromboembolic pulmonary hypertension 97
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 97
Added BiPAP* vs. conventional therapy in acute respiratory failure due to exacerbation of COPD. 95
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease 95
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 95
Glucocorticoid treatment in community-acquired pneumonia 94
Totale 18.398
Categoria #
all - tutte 107.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020779 0 0 0 0 0 0 0 0 0 328 256 195
2020/20213.120 306 197 164 343 217 232 252 330 199 396 141 343
2021/20223.205 162 240 142 239 107 187 202 144 464 319 302 697
2022/20234.120 430 488 373 472 339 654 104 309 434 66 286 165
2023/20244.444 175 153 231 183 275 447 585 770 106 228 752 539
2024/20258.602 899 1.351 982 1.058 697 637 510 514 1.001 953 0 0
Totale 30.785